Direct Lentiviral Injection Gene Therapy for MLD
Clinical trial NCT03725670 · RECRUITING
Trial details
- NCT number
- NCT03725670
- Sponsor
- Shenzhen Geno-Immune Medical Institute
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-31
- Primary completion
- 2029-12-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.